Evidence map›Paper›PMID 39048129›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2024

Overlooked, dismissed, and downplayed: reversion of

Katie D Dale, Alvaro Schwalb, Anna K Coussens, Katherine B Gibney, Alison J Abboud, Krista Watts, Justin T Denholm

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. BCG Revaccination for the Prevention ofThe New England journal of medicine · 2025
    Trial
  2. Lancet regional health. Americas · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katie D DaleVictorian Tuberculosis Program, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia katie.dale@mh.org.au.
Alvaro SchwalbTB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
Anna K CoussensInfectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.ORCID https://orcid.org/0000-0002-7086-2621
Katherine B GibneyVictorian Tuberculosis Program, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Alison J AbboudDepartment of Infectious Diseases, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Krista WattsVictorian Tuberculosis Program, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Justin T DenholmVictorian Tuberculosis Program, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID https://orcid.org/0000-0002-9214-6431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is caused by

Indexed as

Interferon-gamma Release TestsMycobacterium tuberculosisPredictive Value of TestsTuberculin TestTuberculosisAntigens, BacterialBiomarkersDisease ProgressionHost-Pathogen InteractionsHumansPrognosisRisk AssessmentRisk FactorsTime FactorsAntigens, BacterialBiomarkers

Identifiers

PMID39048129
PMCPMC11267292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.